ODAN-ETHOSUXIMIDE

Identification of Odan-Ethosuximide

No description

Google image searchProduct monograph

Active ingredient

ethosuximide, 250 MG

DIN: 02547171

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: ODAN LABORATORIES LTD

Date: 25-JUN-2024

ATC:

• N03 — ANTIEPILEPTICS (ATC, ATC/DDD, )
• N03A — ANTIEPILEPTICS (ATC, ATC/DDD)
• N03AD — Succinimide derivatives (ATC, ATC/DDD)
• N03AD01 — ETHOSUXIMIDE (ATC/DDD)

Reference brand drug: Zarontin

Pharmaceutical standard: USP

External Links for Odan-Ethosuximide

Search on Google

• Odan-Ethosuximide side effects
• Odan-Ethosuximide dosage
• ethosuximide side effects
• ethosuximide dosage

Odan Laboratories Ltd

Go to Odan Laboratories website to see drug product details. Sometimes you can find odan-ethosuximide photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.